Polyubiquitination of Transforming Growth Factor β-activated Kinase 1 (TAK1) at Lysine 562 Residue Regulates TLR4-mediated JNK and p38 MAPK Activation

被引:0
|
作者
I-Ting Chen
Pang-Hung Hsu
Wan-Ching Hsu
Nien-Jung Chen
Ping-Hui Tseng
机构
[1] Institute of Biochemistry and Molecular Biology,
[2] School of Life Sciences,undefined
[3] National Yang-Ming University,undefined
[4] Institute of Bioscience and Biotechnology,undefined
[5] College of Life Sciences,undefined
[6] National Taiwan Ocean University,undefined
[7] Institute of Microbiology and Immunology,undefined
[8] School of Life Sciences,undefined
[9] National Yang-Ming University,undefined
[10] Infection and Immunity Research Center,undefined
[11] National Yang-Ming University,undefined
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Toll-like receptor 4 (TLR4) plays an important role in innate immunity by eliciting inflammation. Upon receptor engagement, transforming growth factor β-activated kinase 1 (TAK1) is an essential mediator that transmits a signal from the receptor to downstream effectors, IκB kinase (IKK) and the mitogen-activated protein kinases (MAPKs), which control the production of inflammatory cytokines. However, the association between phosphorylation and ubiquitination of TAK1 is not yet clear. Here, we examined the crosstalk between phosphorylation and polyubiquitination of TAK1 and further investigated the mechanism of distinct activation of MAPKs and IKK. Inhibition of TAK1 phosphorylation enhanced Lys63-linked polyubiquitination of TAK1. Conversely, ubiquitin modification was counteracted by phospho-mimic TAK1 mutant, T(184,187)D. Moreover, using LC-MS analysis, Lys562 of TAK1 was identified as a novel Lys63-linked ubiquitination site and as the key residue in the feedback regulation. Mutation of Lys562 of TAK1 leads to a decrease in TAK1 phosphorylation and specific inhibition of the MAPK pathway, but has no effect on formation of the TAK1-containing complex. Our findings demonstrate a feedback loop for phosphorylation and ubiquitination of TAK1, indicating a dynamic regulation between TAK1 polyubiquitiantion and phosphorylated activation and the molecular mechanism by which IKK and MAPKs are differentially activated in the TLR4 pathway.
引用
收藏
相关论文
共 50 条
  • [1] Polyubiquitination of Transforming Growth Factor β-activated Kinase 1 (TAK1) at Lysine 562 Residue Regulates TLR4-mediated JNK and p38 MAPK Activation
    Chen, I-Ting
    Hsu, Pang-Hung
    Hsu, Wan-Ching
    Chen, Nien-Jung
    Tseng, Ping-Hui
    SCIENTIFIC REPORTS, 2015, 5
  • [2] Solanum nigrum induces macrophage activation through TLR4-mediated activation of JNK and macrophage autophagy through TLR4-mediated activation of p38 and JNK
    Yu, Ju Hyung
    Choi, Min Yeong
    Park, So Jung
    Geum, Na Gyeong
    Lee, Jae Won
    Park, Gwang Hun
    Eo, Hyun Ji
    Jeong, Jin Boo
    FOOD AND AGRICULTURAL IMMUNOLOGY, 2022, 33 (01) : 641 - 651
  • [3] TLR4-mediated IKK and MAPK activation is regulated by differential post-translational modification of TAK1
    Tseng, P. -H.
    Chen, I. -T.
    CYTOKINE, 2012, 59 (03) : 505 - 506
  • [4] TRANSFORMING GROWTH FACTOR β-ACTIVATED KINASE 1 (TAK1) ATTENUATES EXPERIMENTAL GLOMERULONEPHRITIS
    Amos, L.
    Ozols, E.
    Han, Y.
    Nikolic-Paterson, D. J.
    NEPHROLOGY, 2015, 20 : 39 - 40
  • [5] Identification of novel TAK1 and p38 MAPK dependent phosphorylation sites in TAB1, a regulatory subunit of the protein kinase TAK1
    Wolf, A.
    Vahlsing, S.
    Dittrich-Breiholz, O.
    Schneider, H.
    Beuerlein, K.
    Kracht, M.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2009, 379 : 29 - 29
  • [6] Epithelial transforming growth factor β-activated kinase 1 (TAK1) is activated through two independent mechanisms and regulates reactive oxygen species
    Omori, Emily
    Inagaki, Maiko
    Mishina, Yuji
    Matsumoto, Kunihiro
    Ninomiya-Tsuji, Jun
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2012, 109 (09) : 3365 - 3370
  • [7] TAB1β (transforming growth Factor-β-activated protein kinase 1-binding protein 1β), a novel splicing variant of TAB1 that interacts with p38α but not TAK1
    Ge, BX
    Xiong, XS
    Jing, Q
    Mosley, JL
    Filose, A
    Bian, DF
    Huang, S
    Han, JH
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (04) : 2286 - 2293
  • [8] Transforming Growth Factor beta-Activated Kinase 1 (TAK1) is a novel target for retinal neovascularization
    Wang, Jiang-Hui
    Ling, Damien
    Tu, Leilei
    Riaz, Moeen
    Van Wijngaarden, Peter
    Dusting, Gregory
    Liu, Guei-Sheung
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2017, 58 (08)
  • [9] Transforming growth factor-beta activated kinase 1 (TAK1) is a central mediator in rheumatoid arthritis
    Courties, G.
    Seiffart, V.
    Apparailly, F.
    Escriou, V.
    Scherman, D.
    Hoffmann, A.
    Gross, G.
    Jorgensen, C.
    ANNALS OF THE RHEUMATIC DISEASES, 2008, 67 : A17 - A17
  • [10] Tabersonine alleviates obesity-induced cardiomyopathy by binding to Transforming growth factor activated kinase 1 (TAK1) and inhibiting TAK1-mediated inflammation
    Chen, Yanghao
    Lin, Wante
    Chen, Pan
    Ye, Bozhi
    Luo, Wu
    Wang, Xu
    Huang, Weijian
    Wu, Gaojun
    Liang, Guang
    PHYTOTHERAPY RESEARCH, 2023, 37 (03) : 860 - 871